Document Classification

Section Type: RESULTS

Text: Patients who received paclitaxel-eluting stents, as compared with those who received bare-metal stents, had significantly lower 12-month rates of ischemia-driven target-lesion revascularization (4. 5 % vs. 7. 5 % ; hazard ratio, 0. 59 ; 95 % confidence interval [CI], 0. 43 to 0. 83 ; P = 0. 002) and target-vessel revascularization (5. 8 % vs. 8. 7 % ; hazard ratio, 0. 65 ; 95 % CI, 0. 48 to 0. 89 ; P = 0. 006), with noninferior rates of the composite safety end point (8. 1 % vs. 8. 0 % ; hazard ratio, 1. 02 ; 95 % CI, 0. 76 to 1. 36 ; absolute difference, 0. 1 percentage point ; 95 % CI, -2. 1 to 2. 4 ; P = 0. 01 for noninferiority ; P = 0. 92 for superiority).